Chronic lymphocytic leukemia (CLL) is a type of cancer that starts in the blood-forming cells of the bone marrow and then spreads to the blood. Many people suffering from this condition don’t show any symptoms for at least a few years, as the leukemia cells build up slowly. Over time, these cancerous cells can spread to other parts of the body, including the liver, spleen, and the lymph nodes. Many studies of chronic lymphocytic leukemia (CLL) are being done around the world to come up with a new treatment for chronic lymphocytic leukemia that could prevent it, treat it, and provide the best care to those diagnosed with it.

New drugs and drug combinations

To increase the likelihood that patients live longer and have a complete remission, researchers have found new drugs and are doing their best to find a new treatment for chronic lymphocytic leukemia. Different combinations of the already developed treatments, such as targeted therapy and chemotherapy, are also being studied. There are many new drugs for CLL, including latest kinase inhibitors. Additionally, researchers are trying to combine various drugs to create one treatment that is highly effective in treating CLL.

Genetics

Another new treatment for chronic lymphocytic leukemia that is being researched is related to human genetics.

Palliative care

A multidisciplinary approach including specialized medical and nursing care for people suffering from life-limiting illnesses such as CLL is termed as palliative care. It cannot be termed as a new treatment for chronic lymphocytic leukemia but is certainly something that can help patients and their families going through tough times because of CLL. Clinical trials are being done globally to improve palliative care to improve the patient’s quality of life and comfort. It helps alleviate symptoms and stress related to serious illnesses.